印度批准Entod制药公司的PresVu眼滴用于前天草药治疗。 India approves Entod Pharmaceuticals' PresVu eye drops for presbyopia treatment.

Entod制药公司已得到印度PresVu眼滴药物总监的批准,这是第一种旨在治疗与年龄有关的常见视力状况 -- -- 预视性前科 -- -- 的产品。 Entod Pharmaceuticals has received approval from India's Drug Controller General for PresVu eye drops, the first product aimed at treating presbyopia, a common age-related vision condition. 为了减少对阅读眼镜的依赖,PresVu将从10月开始在药店购买350卢比,只开处方。 Designed to reduce reliance on reading glasses, PresVu will be available in pharmacies starting in October for Rs 350, by prescription only. 该公司计划在国内和新兴市场销售这些滴剂，同时探索心理健康方面的未来创新。 The company plans to market the drops domestically and in emerging markets, while also exploring future innovations in mental health.